D
David Lee Nelson
Researcher at UFVJM
Publications - 165
Citations - 2566
David Lee Nelson is an academic researcher from UFVJM. The author has contributed to research in topics: Essential oil & Receptor. The author has an hindex of 27, co-authored 162 publications receiving 2265 citations. Previous affiliations of David Lee Nelson include University Center of Belo Horizonte & Universidade Federal de Minas Gerais.
Papers
More filters
Journal Article
Pharmacologic characterization of the human 5-hydroxytryptamine2B receptor: evidence for species differences.
TL;DR: The cloned human 5-HT2B receptor has high affinity for [3H]5-HT (Kd = 10.6 +/- 1.5 nM), and the pharmacological findings reinforce the desirability of having the human forms of receptors when considering drug actions.
Journal ArticleDOI
Spiroxatrine: a selective serotonin1A receptor antagonist.
Journal Article
Multiple Subtypes of Serotonin Receptors Are Expressed in Rat Sensory Neurons in Culture
Joanne J. Chen,Michael R. Vasko,Xiaoping Wu,Teodora Staeva,Melvyn Baez,John M. Zgombick,David Lee Nelson +6 more
TL;DR: The identification of multiple subtypes of serotonin receptors expressed in cultured embryonic sensory neurons suggests that DRG neuronal cultures may be an excellent model to examine the direct effects of serotonin on the activity of these sensory neurons.
Journal ArticleDOI
Pharmacologic Characterization of the Cloned Human Trace Amine-Associated Receptor1 (TAAR1) and Evidence for Species Differences with the Rat TAAR1
David B. Wainscott,Sheila P. Little,Tinggui Yin,Yuan Tu,Vincent Patrick Rocco,John Xiaoqiang He,David Lee Nelson +6 more
TL;DR: The TAAR1 receptor exhibits a pharmacologic profile uniquely different from those of classic monoaminergic receptors, consistent with the structural information that places them in a distinct family of receptors, and suggests the potential for development of TAAR-selective agonists and antagonists to study their physiologic roles.
Journal ArticleDOI
Improvement of in vitro efficacy of a novel schistosomicidal drug by incorporation into nanoemulsions.
Sávia Caldeira de Araújo,Ana Carolina Alves de Mattos,Helder Ferreira Teixeira,Paulo Marcos Zech Coelho,David Lee Nelson,Mônica Cristina de Oliveira +5 more
TL;DR: The development and evaluation of the capacity of nanoemulsions to improve the activity of the novel schistosomicidal drug-2-(butylamino)-1-phenyl-1-ethanethiosulfuric acid (BphEA) and release studies revealed a good stability of NANOSTE containing BphEA in a biological medium indicate that cationic nanoemulesions can represent an interesting delivery system for the pharmaceutical formulation of Bph EA.